ADAM-17: A central regulator of angiogenesis

被引：1
|
作者：
Gooz, P. [1 ]
Gooz, M. [1 ]
Baldys, A. [1 ]
Hoffman, S. [1 ]
机构：
[1] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
来源：
MATRIX BIOLOGY | 2006年 / 25卷
关键词：
D O I：
10.1016/j.matbio.2006.08.154
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：S55 / S56
页数：2
相关论文
共 50 条
  • [21] A Disintegrin and Metalloprotease-17 (ADAM-17) Is Expressed In Rheumatoid Arthritis and Mediates Monocyte Migration
    Isozaki, Takeo
    Oguro, Nao
    Seki, Shinya
    Miura, Yoko
    Ishii, Sho
    Tsukamoto, Hiroyuki
    Tokunaga, Takahiro
    Umemura, Masayu
    Furuya, Hidekazu
    Yanai, Ryo
    Isojima, Sakiko
    Wakabayashi, Kuninobu
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S401 - S402
  • [22] Targeting ADAM-17 to Alleviate Cytokine Storm Associated with COVID-19
    Pereira, Vitoria Mattos
    Pradhanang, Suyasha
    Thakar, Amit
    Mansell, John
    Nair, Sreejayan
    FASEB JOURNAL, 2022, 36
  • [23] ADAM-17 Is Activated by the Mitogenic Protein Kinase ERK in a Model of Kidney Fibrosis
    Bell, Hannah L.
    Goeoez, Monika
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (02): : 105 - 107
  • [24] Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease
    Airi Nishimi
    Takeo Isozaki
    Shinichiro Nishimi
    Sho Ishii
    Takahiro Tokunaga
    Hidekazu Furuya
    Kuninobu Wakabayashi
    Tsuyoshi Kasama
    Clinical Rheumatology, 2018, 37 : 1025 - 1026
  • [25] ADAM-17 IS EXPRESSED IN THE INFLAMMATORY MYOPATHY, AND IS INVOLVED WITH INTERSTITIAL LUNG DISEASE (ILD)
    Nishimi, A.
    Isozaki, T.
    Nishimi, S.
    Ishii, S.
    Tokunaga, T.
    Furuya, H.
    Wakabayashi, K.
    Kasama, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 894 - 894
  • [26] ADAM-17 expression in spinal cord white matter of Lewis rats with EAE
    Plumb, J
    Bunning, R
    Cross, A
    Surr, J
    Haddock, G
    Smith, T
    Woodroofe, N
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 116 - 116
  • [27] ADAM-17 Concentration Is Increased in Severe Alpha-1-Antitrypsin Deficiency
    Leacy, E.
    Proceviat, D.
    Alhaddah, L.
    Sharma, A.
    He, Y.
    Annie, C. M.
    Murphy, M. P.
    Herron, M.
    Mcelvaney, N. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [28] Clinical relevance of plasma ADAM-17 with cognition and neurodegeneration in Alzheimer's disease
    Chen, Zu-Qi
    Wang, Meng-Ting
    Tan, Cheng-Rong
    Huang, Shan
    Zhou, Fa-Ying
    Shen, Ying-Ying
    Zeng, Gui-Hua
    Fan, Dong-Yu
    Wang, Yan-Jiang
    JOURNAL OF ALZHEIMERS DISEASE, 2025, 104 (02) : 429 - 435
  • [29] Directed evolution of single chain antibody library targeting a disintegrin and metalloprotease-17 (ADAM-17)
    Raeeszadeh-Sannazdeh, Maryam
    Do, Linh
    FASEB JOURNAL, 2022, 36
  • [30] ADAM-17 IS RELEVANT TO THE RELEASE OF TNF-α INDUCED BY A SNAKE VENOM METALLOPROTEINASE IN MACROPHAGES
    Caires, Giovanna De Arruda
    Verardo, Camila Vieira
    Leiguez, Elbio
    Gutierrez, Jose M.
    Teixeira, Catarina
    Fernandes, Cristina Maria
    TOXICON, 2019, 168 : S22 - S22
12345